Lifeward LFWD
NASDAQ LFWD
$5.94 +0.06 (+1.02%)
At close: Nov 9, 2026 · 4:00 PM EST

Lifeward (LFWD) Net Long-Term Debt Issued (Repaid) (2016 - 2026)

Updated

Lifeward (LFWD) posted Net Long-Term Debt Issued (Repaid) of $2.98 million for Q1 2026.

Analysis

Lifeward (LFWD) Net Long-Term Debt Issued (Repaid) (2016 - 2026) Analysis & Trends

For FY2025, Lifeward's Net Long-Term Debt Issued (Repaid) came in at $1.44 million.

  • The Q1 2026 figure stands as the highest quarterly Net Long-Term Debt Issued (Repaid) since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn -1.11 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn -1.33 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn -
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn -
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn -
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn -
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn -
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn -
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn -2.00 Bn
10 Lifeward 16.92 Mn -8.12 Mn 2.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.98 Mn
Dec 31, 2020 -2.98 Mn
Sep 30, 2020 -1.39 Mn
Jun 30, 2020 -1.33 Mn
Mar 31, 2020 -1.27 Mn
Dec 31, 2019 -461,000.00
Sep 30, 2019 -440,000.00
Jun 30, 2019 -420,000.00
Mar 31, 2019 -401,000.00
Dec 31, 2018 -803,000.00
Sep 30, 2018 -792,000.00
Jun 30, 2018 -1.16 Mn
Mar 31, 2018 -1.12 Mn
Dec 31, 2017 -355,000.00
Sep 30, 2017 -333,000.00
Jun 30, 2017 -1.25 Mn
Mar 31, 2017 -1.17 Mn
Dec 31, 2016 7.13 Mn
Sep 30, 2016 -1,000.00
Mar 31, 2016 11.45 Mn
API Access

Lifeward Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LFWD&period=max&api_key=YOUR_API_KEY